SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NTII - Miscellaneous
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
1296 22 0 NTII
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5712002 - [Memantine][Memantine/Aricept Trial Results] Memantine/Aricept(R) Trial John McCarthy-12/10/2002
5702002 - [Memantine]<b>[Neuroprotection of beta-amyloid(1-40).]</b> 1John McCarthy-12/9/2002
5692002 - [KIF17 protein][learning and memory] Revving up motor protein boosts memJohn McCarthy-12/8/2002
5682002 - [PSD-95][NMDA receptors and stroke therapy][Lancet] NMDA receptors and sJohn McCarthy-12/8/2002
5672002 - [GSK-3][Glycogen synthase kinase-3 is associated with neuronal and glial John McCarthy-12/8/2002
5662002 - [GSK-3 mediates the neurotoxic effects of beta-amyloid] Since the mid-19John McCarthy-12/8/2002
5652002 - [Marijuana and Medicine] Cells of the Immune System The various organs John McCarthy-12/8/2002
5642002 - [Ebixa][Scientific Discussion] eudra.orgJohn McCarthy-12/6/2002
5632002 - [Blocking the pathway to excitotoxicity] Nature Reviews Neuroscience 3, John McCarthy-12/5/2002
562200X - [Targacept Inc][alpha-7 acetylcholine] 1: J Biol Chem 2002 Nov 22;277(47John McCarthy-12/5/2002
5612002 - [Targacept Identifies Key Pathway Regulating Neuroprotection] Targacept John McCarthy-12/5/2002
5602002 - [Memantine][acoustic startle in rats] 1: Psychopharmacology (Berl) 2002 John McCarthy-12/3/2002
5592002 - [Memantine][May][London-APC/DTC]Briefing Memantine for Alzheimers DiseasJohn McCarthy-12/2/2002
5582002 - [First-in-class Ebixa treats severe Alzheimer’s] October 11, 2002 ArticlJohn McCarthy-12/1/2002
5572002 - [AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY] 12/8/2002 - 12/14/2002 SeleJohn McCarthy-11/30/2002
5562002 - [Investor Information Update] <b> Special Note</b> <i>John McCarthy-11/30/2002
5552002 - [Memantine][methamphetamine][Effects of the NMDA antagonist memantine on John McCarthy-11/30/2002
5542002 - [Memantine][Glutamate receptors as a target for Alzheimer's disease--John McCarthy-11/30/2002
5532002 - [Memantine][Measuring cognition in advanced Alzheimer's disease for cJohn McCarthy-11/30/2002
5522002 - [Memantine][citrulline and muscle hyperactivity] <i> Pretreatment John McCarthy-11/28/2002
5512001 - [CNS Market Size][PriceeaterhouseCoopers Securities] July, 2001 - 48 pagJohn McCarthy-11/28/2002
5502002 - [Y-secretase][Arguing AGAINST it as the cause of AD] Abstract It is John McCarthy-11/27/2002
5492002 - [Link][mGlu Receptors] bris.ac.ukJohn McCarthy-11/27/2002
5482002 - [OffTopic][Lab Miniaturization] Note:Summary of Companies <b>CurrJohn McCarthy-11/24/2002
5472002 - [Memantine][International Narcotics Research Conference Asilomar, PacificJohn McCarthy-11/23/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News